<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Washington, D.C.&nbsp; 20549&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM&nbsp;8-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CURRENT REPORT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Pursuant to Section&nbsp;13 or 15(d)&nbsp;of
the Securities Exchange Act of 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event reported):
April 27, 2012</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 24pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SYMMETRY MEDICAL INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Exact name of Registrant as specified
in its charter)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE ALIGN="CENTER" CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR>
    <TD STYLE="width: 32%; vertical-align: top; font-weight: bold; text-align: center">Delaware</TD>
    <TD STYLE="width: 1%; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="width: 32%; vertical-align: top; font-weight: bold; text-align: center">001-32374</TD>
    <TD STYLE="width: 1%; vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="width: 32%; vertical-align: top; font-weight: bold; text-align: center">35-1996126</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(State or other jurisdiction</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>of incorporation)</B></P></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-weight: bold; text-align: center">(Commission File Number)</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: top">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(IRS Employer</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Identification No.)</B></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>3724 N State Road 15, Warsaw, Indiana
46582</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Address of Principal executive offices,
including Zip Code)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(574) 268-2252</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Registrant&rsquo;s telephone number,
including area code)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Former name or former address, if changed
since last report)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px; font-family: Wingdings">o</TD>
    <TD>Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px; font-family: Wingdings">o</TD>
    <TD>Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px; font-family: Wingdings">o</TD>
    <TD>Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 24px; font-family: Wingdings">o</TD>
    <TD>Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.45pt 0pt 0; text-align: justify"><B><U>Item 5.02 Departure of
Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.45pt 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.45pt 0pt 0; text-align: justify; text-indent: 0.5in">Effective
April 27, 2012 Thomas Chorman retired as a Director from the Company&rsquo;s Board of Directors. He served on the Board of Directors
for a term of three years, during which time he served as the Chairman of the Finance &amp; Systems Committee. His retirement was
not related to any disagreements with the Company, the Board or management.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.45pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.45pt 0pt 0; text-align: justify; text-indent: 0.5in">On April
27, 2012 the Board of Directors agreed to provide Brian Moore, the Company&rsquo;s President of Business Development, with ongoing
payments equal to the cost of COBRA coverage he incurs upon his retirement on June 30, 2012. The payments will continue through
the earlier of his COBRA coverage expiration or the date he obtains group medical coverage through a subsequent employer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.45pt 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.45pt 0pt 0; text-align: justify"><B><U>Item 5.03. Amendments
to Articles of Incorporation or Bylaws; Change in Fiscal Year.</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.45pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.45pt 0pt 0; text-align: justify; text-indent: 0.5in">On April
27, 2012 the Board of Directors, acting pursuant to Article III, Section 2 of the Company&rsquo;s Amended and Restated Bylaws,
decreased the size of the Board to six (6) members from its former seven (7) members.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Item&nbsp;5.07</U> <U>Submission of Matters of a Vote
of Security Holders</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Annual Meeting
of Shareholders of Symmetry Medical Inc. was held on Friday, April 27, 2012.&nbsp;&nbsp;The Board of Directors fixed the close
of business on March 5, 2012 as the record date for the determination of stockholders entitled to notice of and to vote at the
Annual Meeting and at any adjournment thereof.&nbsp;&nbsp;On this record date, there were outstanding and entitled to vote 36,579,759
shares of Common Stock. A total of 34,936,176, or 95.5%, were voted at the Annual Meeting. There were three issues proposed for
vote by the stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Proposal 1</B>- Election of Class I Directors. Voting for
the Class I Directors elected to serve for a term of three years is summarized as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 75%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="width: 40%">John S. Krelle:</TD>
    <TD NOWRAP STYLE="width: 33%">For</TD>
    <TD NOWRAP STYLE="width: 27%; text-align: right">30,113,876</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP>Withheld</TD>
    <TD NOWRAP STYLE="text-align: right">3,327,098</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP>Non Votes</TD>
    <TD NOWRAP STYLE="text-align: right">1,495,202</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Robert G. Deuster:</P></TD>
    <TD NOWRAP>For</TD>
    <TD NOWRAP STYLE="text-align: right">30,128,268</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP>Withheld</TD>
    <TD NOWRAP STYLE="text-align: right">3,312,706</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD>
    <TD NOWRAP>Non Votes</TD>
    <TD NOWRAP STYLE="text-align: right">1,495,202</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Proposal 2 &ndash; </B>Advisory vote regarding the Company&rsquo;s
executive compensation program. The results of the advisory vote are summarized as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; border-collapse: collapse; margin-left: 0.5in">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="width: 55%">For</TD>
    <TD NOWRAP STYLE="width: 45%; text-align: right">31,148,438</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>Against</TD>
    <TD NOWRAP STYLE="text-align: right">2,279,922</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>Abstain</TD>
    <TD NOWRAP STYLE="text-align: right">12,614</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>Non Votes</TD>
    <TD NOWRAP STYLE="text-align: right">1,495,202</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At the 2011 Annual
Meeting of Shareholders the Company&rsquo;s Shareholders voted in favor of the Company providing them with annual opportunities
to provide advisory votes regarding the Company&rsquo;s executive compensation program. The Board has adopted that proposal and
will provide the Company&rsquo;s Shareholders with annual opportunities to provide advisory votes regarding the executive compensation
program in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Proposal 3 &ndash;</B> Ratification
and Approval of the appointment of the firm of Ernst &amp; Young LLP as independent auditors of the Company for Fiscal 2012. Voting
on this proposal is summarized as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; border-collapse: collapse; margin-left: 0.5in">
<TR>
    <TD NOWRAP STYLE="width: 55%; vertical-align: bottom">For</TD>
    <TD NOWRAP STYLE="width: 45%; vertical-align: top; color: #333333; text-align: right">34,108,534</TD></TR>
<TR>
    <TD NOWRAP STYLE="vertical-align: bottom">Against</TD>
    <TD NOWRAP STYLE="vertical-align: top; color: #333333; text-align: right">827,074</TD></TR>
<TR>
    <TD NOWRAP STYLE="vertical-align: bottom">Abstain</TD>
    <TD NOWRAP STYLE="vertical-align: top; color: #333333; text-align: right">568</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Proposal 4</B> &ndash;&nbsp;Ratification and Approval of
the amendment to the Company&rsquo;s Amended and Restated 2004 Equity Incentive Plan. Voting on this proposal is summarized as
follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; border-collapse: collapse; margin-left: 0.5in">
<TR>
    <TD NOWRAP STYLE="width: 55%; vertical-align: bottom">For</TD>
    <TD NOWRAP STYLE="width: 45%; vertical-align: top; color: #333333; text-align: right">26,213,063</TD></TR>
<TR>
    <TD NOWRAP STYLE="vertical-align: bottom">Against</TD>
    <TD NOWRAP STYLE="vertical-align: top; color: #333333; text-align: right">7,180,917</TD></TR>
<TR>
    <TD NOWRAP STYLE="vertical-align: bottom">Abstain</TD>
    <TD NOWRAP STYLE="vertical-align: top; color: #333333; text-align: right">46,494</TD></TR>
<TR>
    <TD NOWRAP STYLE="vertical-align: bottom">Non Votes</TD>
    <TD NOWRAP STYLE="vertical-align: top; color: #333333; text-align: right">1,495,202</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 40%; font-weight: bold">Symmetry Medical Inc.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">/s/ Fred L. Hite</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>Date: April 30, 2012</TD>
    <TD>Name:&nbsp; Fred L. Hite</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Title:&nbsp;&nbsp;&nbsp; Chief Financial Officer</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font-size: 10pt"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "v311204_8k.htm", "description": "8-K", "secsgml_size_bytes": 18853}]
{"company-data": {"conformed-name": "Symmetry Medical Inc.", "cik": "0001292055", "assigned-sic": "3842", "irs-number": "351996126", "state-of-incorporation": "DE", "fiscal-year-end": "0101"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-32374", "film-number": "12805532"}, "business-address": {"street1": "3724 N STATE ROAD 15", "city": "WARSAW", "state": "IN", "zip": "46582", "phone": "574-268-2252"}, "mail-address": {"street1": "3724 N STATE ROAD 15", "city": "WARSAW", "state": "IN", "zip": "46582"}}
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
April 27, 2012
SYMMETRY MEDICAL INC.
(Exact name of Registrant as specified
in its charter)
Delaware
001-32374
35-1996126
(State or other jurisdiction
of incorporation)
(Commission File Number)
(IRS Employer
Identification No.)
3724 N State Road 15, Warsaw, Indiana
46582
(Address of Principal executive offices,
including Zip Code)
(574) 268-2252
(Registrant's telephone number,
including area code)
(Former name or former address, if changed
since last report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.02 Departure of
Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Effective
April 27, 2012 Thomas Chorman retired as a Director from the Company's Board of Directors. He served on the Board of Directors
for a term of three years, during which time he served as the Chairman of the Finance & Systems Committee. His retirement was
not related to any disagreements with the Company, the Board or management.
On April
27, 2012 the Board of Directors agreed to provide Brian Moore, the Company's President of Business Development, with ongoing
payments equal to the cost of COBRA coverage he incurs upon his retirement on June 30, 2012. The payments will continue through
the earlier of his COBRA coverage expiration or the date he obtains group medical coverage through a subsequent employer.
Item 5.03. Amendments
to Articles of Incorporation or Bylaws; Change in Fiscal Year.
On April
27, 2012 the Board of Directors, acting pursuant to Article III, Section 2 of the Company's Amended and Restated Bylaws,
decreased the size of the Board to six (6) members from its former seven (7) members.
Item 5.07
Submission of Matters of a Vote
of Security Holders
The Annual Meeting
of Shareholders of Symmetry Medical Inc. was held on Friday, April 27, 2012.  The Board of Directors fixed the close
of business on March 5, 2012 as the record date for the determination of stockholders entitled to notice of and to vote at the
Annual Meeting and at any adjournment thereof.  On this record date, there were outstanding and entitled to vote 36,579,759
shares of Common Stock. A total of 34,936,176, or 95.5%, were voted at the Annual Meeting. There were three issues proposed for
vote by the stockholders.
Proposal 1
- Election of Class I Directors. Voting for
the Class I Directors elected to serve for a term of three years is summarized as follows:
John S. Krelle:
For
30,113,876
Withheld
3,327,098
Non Votes
1,495,202
Robert G. Deuster:
For
30,128,268
Withheld
3,312,706
Non Votes
1,495,202
Proposal 2 –
Advisory vote regarding the Company's
executive compensation program. The results of the advisory vote are summarized as follows:
For
31,148,438
Against
2,279,922
Abstain
12,614
Non Votes
1,495,202
At the 2011 Annual
Meeting of Shareholders the Company's Shareholders voted in favor of the Company providing them with annual opportunities
to provide advisory votes regarding the Company's executive compensation program. The Board has adopted that proposal and
will provide the Company's Shareholders with annual opportunities to provide advisory votes regarding the executive compensation
program in the future.
Proposal 3 –
Ratification
and Approval of the appointment of the firm of Ernst & Young LLP as independent auditors of the Company for Fiscal 2012. Voting
on this proposal is summarized as follows:
For
34,108,534
Against
827,074
Abstain
568
Proposal 4
– Ratification and Approval of
the amendment to the Company's Amended and Restated 2004 Equity Incentive Plan. Voting on this proposal is summarized as
follows:
For
26,213,063
Against
7,180,917
Abstain
46,494
Non Votes
1,495,202
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
Symmetry Medical Inc.
/s/ Fred L. Hite
Date: April 30, 2012
Name:  Fred L. Hite
Title:    Chief Financial Officer